Lack Of FDA Trial Authority, DTC Marketing Caused COX-2 Crisis – Topol

Evaluation of naproxen safety should be postponed until final data from NIH's ADAPT trial is released, Cleveland Clinic cardiologist Eric Topol, MD, advocates